The European Food Safety Authority (EFSA) has released a scientific opinion aimed at evaluating the safety of a novel food ingredient, 6′-sialyllactose (6′-SL) sodium salt, produced using a derivative strain of Escherichia coli K-12 MG1655. This move is poised to attract significant attention from food industry players, especially manufacturers of infant formula and dietary supplements, as well as regulatory bodies and consumer advocacy groups concerned with food safety.
The opinion was published on January 30, 2026, by EFSA, the European Union's specialized agency responsible for independent scientific advice on food and feed safety. EFSA operates through several panels, including the Panel on Nutrition, Novel Foods and Food Allergens, which likely led this assessment.
This document constitutes a scientific opinion rather than binding legislation. Its provisions are advisory and serve as a critical risk assessment that informs the European Commission and Member States when considering the authorization of novel foods under Regulation (EU) 2015/2283. The opinion includes detailed evaluations of the production process, genetic modification of the E. coli strain, toxicological data, and potential allergenicity, but does not specify concrete regulatory measures such as mandatory labeling or production standards.
EFSA's assessment sets a policy orientation favoring consumer safety and scientific rigor in supporting novel food approvals. It weighs potential benefits such as introducing innovative prebiotic compounds against concerns about genetically modified production methods and the need for thorough safety demonstrations. This reflects a cautious approach that prioritizes public health while enabling technological advancement in the food sector.
novel food producers in the biotechnology and infant nutrition sectors may welcome the scientific backing facilitating market entry, while some consumer groups may remain vigilant due to the involvement of genetically modified microorganisms. National food safety authorities gain a reference to align regulatory decisions, though the obligation to regulate remains with Member States. EFSA itself strengthens its role as a neutral scientific evaluator, reinforcing transparency and trust in food safety assessment.
This publication marks a continuation of EFSA's ongoing role in pioneering safety evaluations of novel foods within the EU regulatory framework. It sets the stage for subsequent regulatory steps by the European Commission and potential market authorization processes by Member States, reflecting the dynamic interplay between science, policy, and industry in European food regulation.
← Atlas › News